Literature DB >> 15028329

Are 1-2 tablets dangerous? Beta-blocker exposure in toddlers.

Jeffrey N Love1, Neal Sikka.   

Abstract

The common use and wide availability of beta-adrenergic blocking agents make them frequent ingestants for small children. Yet, there are no clear guidelines in the literature to direct the care of the toddler with the history of ingesting 1-2 tablets. With 40 years of extensive clinical experience, not one documented case of death or serious cardiovascular morbidity as a direct result of a beta-blocker exposure is to be found in an English language review for children under 6 years of age. As with children on chronic beta-blocker therapy, several cases of symptomatic hypoglycemia associated with a single acute propranolol exposure suggest a vulnerability to this complication. Though the risk to the toddler exposed to 1-2 tablets appears to be extremely small, several factors mitigate the actual risk to the child and the need for triage to a health care facility.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15028329     DOI: 10.1016/j.jemermed.2003.11.015

Source DB:  PubMed          Journal:  J Emerg Med        ISSN: 0736-4679            Impact factor:   1.484


  17 in total

1.  Treatment with propranolol for infantile hemangiomas: A case series of 106 infants.

Authors:  Shang-Bin Li; Guang-Qi Xu; Feng Gao; Ran Huo
Journal:  Exp Ther Med       Date:  2015-05-08       Impact factor: 2.447

2.  Comparison of Efficacy and Safety Between Propranolol and Steroid for Infantile Hemangioma: A Randomized Clinical Trial.

Authors:  Kyu Han Kim; Tae Hyun Choi; Yunhee Choi; Young Woon Park; Ki Yong Hong; Dong Young Kim; Yun Seon Choe; Hyunjung Lee; Jung-Eun Cheon; Jung-Bin Park; Kyung Duk Park; Hyoung Jin Kang; Hee Young Shin; Jae Hoon Jeong
Journal:  JAMA Dermatol       Date:  2017-06-01       Impact factor: 10.282

Review 3.  The use of propranolol in the management of periocular capillary haemangioma--a systematic review.

Authors:  K Spiteri Cornish; A R Reddy
Journal:  Eye (Lond)       Date:  2011-07-08       Impact factor: 3.775

4.  Vascular Anomalies: A Pediatric Surgeon's Perspective.

Authors:  Alisha Gupta; Ajay Verma; Anjan Dhua; Veereshwar Bhatnagar
Journal:  Indian J Pediatr       Date:  2017-05-03       Impact factor: 1.967

5.  Efficacy and safety of propranolol as first-line treatment for infantile hemangiomas.

Authors:  Clemens Schiestl; Kathrin Neuhaus; Silke Zoller; Ulrike Subotic; Ishilde Forster-Kuebler; Rike Michels; Christian Balmer; Lisa Weibel
Journal:  Eur J Pediatr       Date:  2010-10-09       Impact factor: 3.183

6.  Topical treatment with propranolol gel as a supplement to the existing treatment of hemangiomas.

Authors:  Markus Schneider; Andreas Reimer; Hansjoerg Cremer; Peter Ruef
Journal:  World J Pediatr       Date:  2014-12-17       Impact factor: 2.764

7.  Propranolol therapy for cutaneous infantile haemangiomas initiated safely as a day-case procedure.

Authors:  Edward McSwiney; Deirdre Murray; Michelle Murphy
Journal:  Eur J Pediatr       Date:  2013-08-11       Impact factor: 3.183

8.  New indication for therapeutic potential of an old well-known drug (propranolol) for multiple myeloma.

Authors:  Ilknur Kozanoglu; Melis Kartal Yandim; Zeynep Birsu Cincin; Hakan Ozdogu; Bedia Cakmakoglu; Yusuf Baran
Journal:  J Cancer Res Clin Oncol       Date:  2012-10-19       Impact factor: 4.553

Review 9.  Propranolol is an effective treatment for airway haemangiomas: a critical analysis and meta-analysis of published interventional studies.

Authors:  P V Vlastarakos; G X Papacharalampous; M Chrysostomou; E-F Tavoulari; A Delidis; D Protopapas; T P Nikolopoulos
Journal:  Acta Otorhinolaryngol Ital       Date:  2012-08       Impact factor: 2.124

10.  Propranolol therapy of infantile hemangiomas: efficacy, adverse effects, and recurrence.

Authors:  Qiang Xiao; Qin Li; Bin Zhang; Wenlin Yu
Journal:  Pediatr Surg Int       Date:  2013-03-22       Impact factor: 1.827

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.